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106Ru/106RhConcave beta sources of 106Ru/106Rh are used in radiotherapy to treat ophthalmic tumors. However, a
problem that arises is the difﬁcult determination of absorbed dose distributions around such sources
mainly because of the small range of the electrons and the steep dose gradients. In this sense, numerical
methods have been developed to calculate the dose distributions around the beta applicators. In this
work a simple code in Fortran language is developed to estimate the dose rates along the central axis
of 106Ru/106Rh curved plaques by numerical integration of the beta point source function and results
are compared with other calculated data.
 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Applicators containing the pure beta emitter 106Ru (main com- B qmn qmn
  ponent 106Rh) can be used in ophthalmic brachytherapy for the
treatment of various diseases, such as the retinoblastoma and the
melanomas of the choroid. A serious drawback of the use of these
sources to treat ocular malignancies is the difﬁculty to perform an
accurate dosimetry, mainly because of the high-dose gradient and
the short range of the beta-particles as compared with the size of
detectors, and in some cases the non-uniform distribution of
radioactive material over the plaque surface can bring additional
problems on the measurements. Thus, the calculation methods
increase in importance and there are two general methods of
calculation of dose distribution around beta applicators: Monte
Carlo (MC) simulations and analytical and numerical methods.
Using MC methods is possible to deal with more complex geome-
tries and different media, and obtain results with great accuracy,
but may require a large time of computation; the analytical and
numerical methods are based on the beta point-source dose
integration, and may give results of dose distributions more
rapidly, but apply only for a homogeneous medium.
In this work a Fortran code (which compiler was freely down-
loaded from the web) was developed to estimate the dose rates
along the central axis of CCA and CCB 106Ru applicators by numeri-
cal integration of the beta point-source dose function and the
results are compared with other semi-empirical analytical [1]
and MC calculations [2–5].
The function that describes the absorbed dose rate J nð Þ around a
point beta source as a function of the distance n can be expressed
by [6]JðnÞ ¼
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where q is the medium density and m is the absorption coefﬁcient,
with
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The parameter B is a normalization constant given by
B ¼ 0:046q2m3Eba, where Eb is the mean kinetic energy of the beta
particles, and the constant a depends on the dimensionless parame-
ters c and f. Eq. (1) is a reﬁnement obtained by Vynckier and
Wambersie [6] of the expression ﬁrstly proposed by Loevinger [7]
in order to obtain a better ﬁt of the beta function to experimental
and theoretical data and it is based on the assumption that the
strength of the point source follows an inverse-square law, and
the radiation is attenuated exponentially when it traverses the
medium.
In integration of Eq. (1) the following assumptions were
adopted. The eye is formed by a homogeneous medium of density
q; the radioactive material is uniformly distributed on the concave
surface of each plaque; the encapsulation of radioactive material is
not considered, and the plaque has spherical symmetry. In Fig. 1 is
shown the geometry used in calculation of the dose rate _D inside
the eye by integration of Eq. (1). The source has a constant radius
R and an active diameter d; the angle h is the azimuthal angle in
the xy-plane from the x-axis with 0 6 h 6 2p, and / is the polar
angle from the positive z-axis with 0 6 / 6 /max (/max is deﬁned
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Fig. 1. The geometry of a spherical beta-ray source of radius R and diameter d used
for integration of the beta point dose function. Depth increases from the plaque
center to the origin O.
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Fig. 2. Relative dose rates along the central axis as a function of the depth for the
CCA and CCB 106Ru applicators. Solid lines, this work; , [5]; j, [4]; N, [3]; M, [2]; },
[1].
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generic point P(y0; z0) is
n ¼ R2 þ y20 þ z20  2Rz0 cos /  2Ry0 sin / sin h
 	1=2
: ð2Þ
Thus, the absorbed dose rate _D at P (in plane yz) can be written as
_D ¼ aS
Z
S
JðnÞ  dS ¼ aSR2
ZZ
JðnÞ sin/d/dh; ð3Þ
where aS is the surface activity. This double integration has been
performed by means of a Fortran code based on the trapezoidal rule
and results are compared with analytical and simulation data.
The Fortran code was used to the numerical integration of the
beta point source function (1) to obtain the absorbed dose rates
in the region of interest of the CCA (R ¼ 1:2 cm , d ¼ 1:3 cm) and
CCB (R ¼ 1:2 cm, d ¼ 1:78 cm) curved ophthalmic plaques of
106Ru. In Eqs. (1) through (3) the medium is water; the absorption
coefﬁcient m is 3.57 cm2/g; the mean beta energy per disintegration
Eb is 1.42 MeV; the parameters c; f and a are respectively 0.88, 5.07
and 0.452, and the surface activity aS is 6.5 MBq/cm2 for both
applicators. In Fig. 2 the absorbed dose rates in water are shown
to 106Ru spherical sources. They are plotted against the depth along
the z-axis and are relative to the dose at z ¼ 0:1 cm. For compar-
ison, published relative dose rates obtained by MC simulations
[2–5] and analytical calculation [1] are also shown. For the CCB
plaque a good agreement (differences <3%) was found with theanalytical results of Ref. [1]. However, a poorer agreement with
the MC simulations were found for both plaques mainly at farther
distances from the plaque center, and this disagreement may be
ascribed to the simpliﬁed assumptions adopted.
Despite the simpliﬁed assumptions adopted, the method was
able to reproduce the general trend of dose values on the central
axis of the ophthalmic applicators of 106Ru and can be an auxiliary
tool in dose planning.
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